AIP
INSP icon

Arrowpoint Investment Partners’s Inspire Medical Systems INSP Stock Holding History

Arrowpoint Investment Partners’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,430
Closed -$387K – 460
2025
Q1 		$387K Buy
+2,430
New +$440K 0.05% 449

Other funds holding INSP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DIG
Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Arrowpoint Investment Partners's INSP Position: Q2 2025 in Review

Arrowpoint Investment Partners sold out of Inspire Medical Systems (INSP) in Q2 2025, closing a stake of 2,430 shares — an estimated $387K sold.

Arrowpoint Investment Partners first reported a position in INSP in Q1 2025 and held it in 1 quarter. The position peaked at $387K in Q1 2025. 356 funds tracked by Wall St. Rank hold INSP as of Q2 2025.

  • Arrowpoint Investment Partners reported no remaining Inspire Medical Systems position as of Q2 2025 after selling out during the quarter.
  • Arrowpoint Investment Partners sold 2,430 Inspire Medical Systems shares in Q2 2025, an estimated $387K.
  • Arrowpoint Investment Partners first reported a position in Inspire Medical Systems in Q1 2025 and held it in 1 quarter.
  • Arrowpoint Investment Partners's Inspire Medical Systems position peaked at $387K in Q1 2025.
  • 356 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2025.

Based on Arrowpoint Investment Partners's 13F filing for Q2 2025, filed 13 Aug 2025.